Global and China Dermatomyositis Drug Market Insights, Forecast to 2026

Global and China Dermatomyositis Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Dermatomyositis Drug Product Introduction
1.2 Market Segments
1.3 Key Dermatomyositis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dermatomyositis Drug Market Size Growth Rate by Type
1.4.2 Abatacept
1.4.3 Baricitinib
1.4.4 Dalazatide
1.4.5 Immune Globulin
1.4.6 IMO-8400
1.4.7 Others
1.5 Market by Application
1.5.1 Global Dermatomyositis Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dermatomyositis Drug Market Size, Estimates and Forecasts
2.1.1 Global Dermatomyositis Drug Revenue 2015-2026
2.1.2 Global Dermatomyositis Drug Sales 2015-2026
2.2 Global Dermatomyositis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Dermatomyositis Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Dermatomyositis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Dermatomyositis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Dermatomyositis Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Dermatomyositis Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Dermatomyositis Drug Revenue Forecast by Region (2021-2026)
3 Global Dermatomyositis Drug Competitor Landscape by Players
3.1 Global Top Dermatomyositis Drug Sales by Manufacturers
3.1.1 Global Dermatomyositis Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Dermatomyositis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Dermatomyositis Drug Manufacturers by Revenue
3.2.1 Global Dermatomyositis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Dermatomyositis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dermatomyositis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dermatomyositis Drug Revenue in 2019
3.2.5 Global Dermatomyositis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Dermatomyositis Drug Price by Manufacturers
3.4 Global Dermatomyositis Drug Manufacturing Base Distribution, Product Types
3.4.1 Dermatomyositis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatomyositis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Dermatomyositis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dermatomyositis Drug Market Size by Type (2015-2020)
4.1.1 Global Dermatomyositis Drug Sales by Type (2015-2020)
4.1.2 Global Dermatomyositis Drug Revenue by Type (2015-2020)
4.1.3 Dermatomyositis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dermatomyositis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Dermatomyositis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatomyositis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Dermatomyositis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dermatomyositis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dermatomyositis Drug Market Size by Application (2015-2020)
5.1.1 Global Dermatomyositis Drug Sales by Application (2015-2020)
5.1.2 Global Dermatomyositis Drug Revenue by Application (2015-2020)
5.1.3 Dermatomyositis Drug Price by Application (2015-2020)
5.2 Dermatomyositis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Dermatomyositis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatomyositis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatomyositis Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Dermatomyositis Drug Market Size YoY Growth 2015-2026
6.1.1 China Dermatomyositis Drug Sales YoY Growth 2015-2026
6.1.2 China Dermatomyositis Drug Revenue YoY Growth 2015-2026
6.1.3 China Dermatomyositis Drug Market Share in Global Market 2015-2026
6.2 China Dermatomyositis Drug Market Size by Players (International and Local Players)
6.2.1 China Top Dermatomyositis Drug Players by Sales (2015-2020)
6.2.2 China Top Dermatomyositis Drug Players by Revenue (2015-2020)
6.3 China Dermatomyositis Drug Historic Market Review by Type (2015-2020)
6.3.1 China Dermatomyositis Drug Sales Market Share by Type (2015-2020)
6.3.2 China Dermatomyositis Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Dermatomyositis Drug Price by Type (2015-2020)
6.4 China Dermatomyositis Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Dermatomyositis Drug Sales Forecast by Type (2021-2026)
6.4.2 China Dermatomyositis Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Dermatomyositis Drug Price Forecast by Type (2021-2026)
6.5 China Dermatomyositis Drug Historic Market Review by Application (2015-2020)
6.5.1 China Dermatomyositis Drug Sales Market Share by Application (2015-2020)
6.5.2 China Dermatomyositis Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Dermatomyositis Drug Price by Application (2015-2020)
6.6 China Dermatomyositis Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Dermatomyositis Drug Sales Forecast by Application (2021-2026)
6.6.2 China Dermatomyositis Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Dermatomyositis Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Dermatomyositis Drug Market Size YoY Growth 2015-2026
7.2 North America Dermatomyositis Drug Market Facts & Figures by Country
7.2.1 North America Dermatomyositis Drug Sales by Country (2015-2020)
7.2.2 North America Dermatomyositis Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Dermatomyositis Drug Market Size YoY Growth 2015-2026
8.2 Europe Dermatomyositis Drug Market Facts & Figures by Country
8.2.1 Europe Dermatomyositis Drug Sales by Country
8.2.2 Europe Dermatomyositis Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Dermatomyositis Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Dermatomyositis Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Dermatomyositis Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Dermatomyositis Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Dermatomyositis Drug Market Size YoY Growth 2015-2026
10.2 Latin America Dermatomyositis Drug Market Facts & Figures by Country
10.2.1 Latin America Dermatomyositis Drug Sales by Country
10.2.2 Latin America Dermatomyositis Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dermatomyositis Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Dermatomyositis Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Dermatomyositis Drug Sales by Country
11.2.2 Middle East and Africa Dermatomyositis Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 MedImmune LLC
12.1.1 MedImmune LLC Corporation Information
12.1.2 MedImmune LLC Description and Business Overview
12.1.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
12.1.4 MedImmune LLC Dermatomyositis Drug Products Offered
12.1.5 MedImmune LLC Recent Development
12.2 Neovacs SA
12.2.1 Neovacs SA Corporation Information
12.2.2 Neovacs SA Description and Business Overview
12.2.3 Neovacs SA Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Neovacs SA Dermatomyositis Drug Products Offered
12.2.5 Neovacs SA Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Corporation Information
12.3.2 Novartis AG Description and Business Overview
12.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis AG Dermatomyositis Drug Products Offered
12.3.5 Novartis AG Recent Development
12.4 Octapharma AG
12.4.1 Octapharma AG Corporation Information
12.4.2 Octapharma AG Description and Business Overview
12.4.3 Octapharma AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Octapharma AG Dermatomyositis Drug Products Offered
12.4.5 Octapharma AG Recent Development
12.5 Pfizer Inc
12.5.1 Pfizer Inc Corporation Information
12.5.2 Pfizer Inc Description and Business Overview
12.5.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Inc Dermatomyositis Drug Products Offered
12.5.5 Pfizer Inc Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Corporation Information
12.6.2 Eli Lilly and Company Description and Business Overview
12.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly and Company Dermatomyositis Drug Products Offered
12.6.5 Eli Lilly and Company Recent Development
12.7 F. Hoffmann-La Roche Ltd
12.7.1 F. Hoffmann-La Roche Ltd Corporation Information
12.7.2 F. Hoffmann-La Roche Ltd Description and Business Overview
12.7.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
12.7.4 F. Hoffmann-La Roche Ltd Dermatomyositis Drug Products Offered
12.7.5 F. Hoffmann-La Roche Ltd Recent Development
12.8 Hope Pharmaceuticals Inc
12.8.1 Hope Pharmaceuticals Inc Corporation Information
12.8.2 Hope Pharmaceuticals Inc Description and Business Overview
12.8.3 Hope Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hope Pharmaceuticals Inc Dermatomyositis Drug Products Offered
12.8.5 Hope Pharmaceuticals Inc Recent Development
12.9 Idera Pharmaceuticals Inc
12.9.1 Idera Pharmaceuticals Inc Corporation Information
12.9.2 Idera Pharmaceuticals Inc Description and Business Overview
12.9.3 Idera Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Idera Pharmaceuticals Inc Dermatomyositis Drug Products Offered
12.9.5 Idera Pharmaceuticals Inc Recent Development
12.10 KPI Therapeutics Inc
12.10.1 KPI Therapeutics Inc Corporation Information
12.10.2 KPI Therapeutics Inc Description and Business Overview
12.10.3 KPI Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 KPI Therapeutics Inc Dermatomyositis Drug Products Offered
12.10.5 KPI Therapeutics Inc Recent Development
12.11 MedImmune LLC
12.11.1 MedImmune LLC Corporation Information
12.11.2 MedImmune LLC Description and Business Overview
12.11.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
12.11.4 MedImmune LLC Dermatomyositis Drug Products Offered
12.11.5 MedImmune LLC Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Dermatomyositis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatomyositis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Dermatomyositis Drug Market Segments
Table 2. Ranking of Global Top Dermatomyositis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dermatomyositis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Abatacept
Table 5. Major Manufacturers of Baricitinib
Table 6. Major Manufacturers of Dalazatide
Table 7. Major Manufacturers of Immune Globulin
Table 8. Major Manufacturers of IMO-8400
Table 9. Major Manufacturers of Others
Table 10. Global Dermatomyositis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Dermatomyositis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Dermatomyositis Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Dermatomyositis Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Dermatomyositis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Dermatomyositis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Dermatomyositis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Dermatomyositis Drug Sales Share by Manufacturers (2015-2020)
Table 18. Global Dermatomyositis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Dermatomyositis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatomyositis Drug as of 2019)
Table 20. Dermatomyositis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Dermatomyositis Drug Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Dermatomyositis Drug Price (2015-2020) (USD/Pcs)
Table 23. Dermatomyositis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Dermatomyositis Drug Product Type
Table 25. Date of International Manufacturers Enter into Dermatomyositis Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatomyositis Drug Sales by Type (2015-2020) (K Pcs)
Table 28. Global Dermatomyositis Drug Sales Share by Type (2015-2020)
Table 29. Global Dermatomyositis Drug Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Dermatomyositis Drug Revenue Share by Type (2015-2020)
Table 31. Dermatomyositis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Dermatomyositis Drug Sales Share by Type (2021-2026)
Table 33. Global Dermatomyositis Drug Sales by Application (2015-2020) (K Pcs)
Table 34. Global Dermatomyositis Drug Sales Share by Application (2015-2020)
Table 35. Global Dermatomyositis Drug Sales Share by Application (2021-2026)
Table 36. Global Dermatomyositis Drug Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Dermatomyositis Drug Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Dermatomyositis Drug Revenue Market Share Forecast by Application (2021-2026)
Table 39. China Dermatomyositis Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 40. China Dermatomyositis Drug Sales Share by Company (2015-2020)
Table 41. China Dermatomyositis Drug Revenue (US$ Million) by Company (2015-2020)
Table 42. China Dermatomyositis Drug Sales (K Pcs) by Type (2015-2020)
Table 43. China Dermatomyositis Drug Sales Share by Type (2015-2020)
Table 44. China Dermatomyositis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. China Dermatomyositis Drug Price (K Pcs) by Type (2015-2020)
Table 46. China Dermatomyositis Drug Sales (K Pcs) by Type (2021-2026)
Table 47. China Dermatomyositis Drug Sales Share by Type (2021-2026)
Table 48. China Dermatomyositis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. China Dermatomyositis Drug Revenue Share by Type (2021-2026)
Table 50. China Dermatomyositis Drug Price (K Pcs) by Type (2021-2026)
Table 51. China Dermatomyositis Drug Sales (K Pcs) by Application (2015-2020)
Table 52. China Dermatomyositis Drug Sales Share by Application (2015-2020)
Table 53. China Dermatomyositis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. China Dermatomyositis Drug Sales (K Pcs) by Application (2021-2026)
Table 55. China Dermatomyositis Drug Sales Share by Application (2021-2026)
Table 56. China Dermatomyositis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. China Dermatomyositis Drug Revenue Share by Application (2021-2026)
Table 58. North America Dermatomyositis Drug Sales by Country (2015-2020) (K Pcs)
Table 59. North America Dermatomyositis Drug Sales Market Share by Country (2015-2020)
Table 60. North America Dermatomyositis Drug Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Dermatomyositis Drug Revenue Market Share by Country (2015-2020)
Table 62. Europe Dermatomyositis Drug Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Dermatomyositis Drug Sales Market Share by Country (2015-2020)
Table 64. Europe Dermatomyositis Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Dermatomyositis Drug Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Dermatomyositis Drug Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Dermatomyositis Drug Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Dermatomyositis Drug Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Dermatomyositis Drug Revenue Market Share by Region (2015-2020)
Table 70. Latin America Dermatomyositis Drug Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Dermatomyositis Drug Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Dermatomyositis Drug Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Dermatomyositis Drug Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Dermatomyositis Drug Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Dermatomyositis Drug Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Dermatomyositis Drug Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Dermatomyositis Drug Revenue Market Share by Country (2015-2020)
Table 78. MedImmune LLC Corporation Information
Table 79. MedImmune LLC Description and Business Overview
Table 80. MedImmune LLC Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. MedImmune LLC Dermatomyositis Drug Product
Table 82. MedImmune LLC Recent Development
Table 83. Neovacs SA Corporation Information
Table 84. Neovacs SA Description and Business Overview
Table 85. Neovacs SA Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Neovacs SA Product
Table 87. Neovacs SA Recent Development
Table 88. Novartis AG Corporation Information
Table 89. Novartis AG Description and Business Overview
Table 90. Novartis AG Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Novartis AG Product
Table 92. Novartis AG Recent Development
Table 93. Octapharma AG Corporation Information
Table 94. Octapharma AG Description and Business Overview
Table 95. Octapharma AG Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Octapharma AG Product
Table 97. Octapharma AG Recent Development
Table 98. Pfizer Inc Corporation Information
Table 99. Pfizer Inc Description and Business Overview
Table 100. Pfizer Inc Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Pfizer Inc Product
Table 102. Pfizer Inc Recent Development
Table 103. Eli Lilly and Company Corporation Information
Table 104. Eli Lilly and Company Description and Business Overview
Table 105. Eli Lilly and Company Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Eli Lilly and Company Product
Table 107. Eli Lilly and Company Recent Development
Table 108. F. Hoffmann-La Roche Ltd Corporation Information
Table 109. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 110. F. Hoffmann-La Roche Ltd Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. F. Hoffmann-La Roche Ltd Product
Table 112. F. Hoffmann-La Roche Ltd Recent Development
Table 113. Hope Pharmaceuticals Inc Corporation Information
Table 114. Hope Pharmaceuticals Inc Description and Business Overview
Table 115. Hope Pharmaceuticals Inc Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Hope Pharmaceuticals Inc Product
Table 117. Hope Pharmaceuticals Inc Recent Development
Table 118. Idera Pharmaceuticals Inc Corporation Information
Table 119. Idera Pharmaceuticals Inc Description and Business Overview
Table 120. Idera Pharmaceuticals Inc Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Idera Pharmaceuticals Inc Product
Table 122. Idera Pharmaceuticals Inc Recent Development
Table 123. KPI Therapeutics Inc Corporation Information
Table 124. KPI Therapeutics Inc Description and Business Overview
Table 125. KPI Therapeutics Inc Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. KPI Therapeutics Inc Product
Table 127. KPI Therapeutics Inc Recent Development
Table 128. Marathon Pharmaceuticals LLC Corporation Information
Table 129. Marathon Pharmaceuticals LLC Description and Business Overview
Table 130. Marathon Pharmaceuticals LLC Dermatomyositis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Marathon Pharmaceuticals LLC Product
Table 132. Marathon Pharmaceuticals LLC Recent Development
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Dermatomyositis Drug Players
Table 137. Dermatomyositis Drug Customers List
Table 138. Dermatomyositis Drug Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatomyositis Drug Product Picture
Figure 2. Global Dermatomyositis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Abatacept Product Picture
Figure 4. Baricitinib Product Picture
Figure 5. Dalazatide Product Picture
Figure 6. Immune Globulin Product Picture
Figure 7. IMO-8400 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Dermatomyositis Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Dermatomyositis Drug Report Years Considered
Figure 14. Global Dermatomyositis Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Dermatomyositis Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Dermatomyositis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Dermatomyositis Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Dermatomyositis Drug Sales Market Share by Region in 2019
Figure 19. Global Dermatomyositis Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Dermatomyositis Drug Revenue Market Share by Region in 2019
Figure 21. Global Dermatomyositis Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Dermatomyositis Drug Revenue in 2019
Figure 23. Dermatomyositis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Dermatomyositis Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Dermatomyositis Drug Sales Market Share by Type in 2019
Figure 26. Global Dermatomyositis Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Dermatomyositis Drug Revenue Market Share by Type in 2019
Figure 28. Global Dermatomyositis Drug Market Share by Price Range (2015-2020)
Figure 29. Global Dermatomyositis Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Dermatomyositis Drug Sales Market Share by Application in 2019
Figure 31. Global Dermatomyositis Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Dermatomyositis Drug Revenue Market Share by Application in 2019
Figure 33. China Dermatomyositis Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. China Dermatomyositis Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. China Dermatomyositis Drug Market Share in Global Market 2015-2026
Figure 36. China 5 and 10 Largest Dermatomyositis Drug Players Market Share by Revenue in Dermatomyositis Drug in 2019
Figure 37. China Dermatomyositis Drug Revenue Share by Type (2015-2020)
Figure 38. China Dermatomyositis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 39. China Dermatomyositis Drug Revenue Share by Application (2015-2020)
Figure 40. China Dermatomyositis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Dermatomyositis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Dermatomyositis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Dermatomyositis Drug Sales Market Share by Country in 2019
Figure 44. North America Dermatomyositis Drug Revenue Market Share by Country in 2019
Figure 45. U.S. Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Dermatomyositis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Dermatomyositis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Dermatomyositis Drug Sales Market Share by Country in 2019
Figure 52. Europe Dermatomyositis Drug Revenue Market Share by Country in 2019
Figure 53. Germany Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Dermatomyositis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Dermatomyositis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Dermatomyositis Drug Sales Market Share by Region in 2019
Figure 66. Asia Pacific Dermatomyositis Drug Revenue Market Share by Region in 2019
Figure 67. China Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Dermatomyositis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Dermatomyositis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Dermatomyositis Drug Sales Market Share by Country in 2019
Figure 92. Latin America Dermatomyositis Drug Revenue Market Share by Country in 2019
Figure 93. Mexico Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Dermatomyositis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Dermatomyositis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Dermatomyositis Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Dermatomyositis Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Dermatomyositis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Dermatomyositis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Dermatomyositis Drug Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs